61 - 70 out of 214Page size: 10
  1. 2017

  2. Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial

    Busard, C., Menting, S., van Bezooijen, S-J., van den Reek, J., Hutten, B., Prens, E., de Jong, E., van Doorn, M. & Spuls, P., 2017, In: Trials. 18, 1, p. 52

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)

    Busard, C., Menting, S., van Bezooijen, S-J., van den Reek, J., Hutten, B., Prens, E., de Jong, E., van Doorn, M. & Spuls, P., 2017, In: Trials. 18, 1, p. 113

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  4. Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients

    Dietz, S. M., Kuipers, I. M., Koole, J. C. D., Breur, J. M. P. J., Fejzic, Z., Frerich, S., Dalinghaus, M., Roest, A. A. W., Hutten, B. A. & Kuijpers, T. W., 2017, In: Pediatric cardiology. 38, 4, p. 833-839

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia

    Besseling, J., Reitsma, J. B., Gaudet, D., Brisson, D., Kastelein, J. J. P., Hovingh, G. K. & Hutten, B. A., 2017, In: European heart journal. 38, 8, p. 565-573

    Research output: Contribution to journal › Article › Academic › peer-review

  6. 2016

  7. PO-28 - Protein C levels are associated with mortality in patients with advanced cancer

    Wilts, I. T., Hutten, B. A., Meijers, J. C., Spek, C. A., Büller, H. R. & Kamphuisen, P. W., Apr 2016, In: Thrombosis research. 140 Suppl 1, p. S186-7

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Children with hypercholesterolemia of unknown cause: Value of genetic risk scores

    Sjouke, B., Tanck, M. W. T., Fouchier, S. W., Defesche, J. C., Hutten, B. A., Wiegman, A., Kastelein, J. J. P. & Hovingh, G. K., 2016, In: Journal of clinical lipidology. 10, 4, p. 851-859

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia

    Besseling, J., Huijgen, R., Martin, S. S., Hutten, B. A., Kastelein, J. J. P. & Hovingh, G. K., 2016, In: Atherosclerosis. 246, p. 1-6

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Extracardial Vasculopathy After Kawasaki Disease: A Long-Term Follow-up Study

    Dietz, S. M., Tacke, C. E., de Groot, E., Kuipers, I. M., Hutten, B. A., Kuijpers, T. W. & AUTHOR GROUP, 2016, In: Journal of the American Heart Association. 5, 7, p. e003414

    Research output: Contribution to journal › Article › Academic › peer-review

  11. In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate

    Barco, S., Whitney Cheung, Y., Coppens, M., Hutten, B. A., Meijers, J. C. M. & Middeldorp, S., 2016, In: British journal of haematology. 172, 2, p. 255-261

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Is there a link between diabetes and cholesterol metabolism?

    Besseling, J. & Hutten, B. A., 2016, In: Expert review of cardiovascular therapy. 14, 3, p. 259-261

    Research output: Contribution to journal › Editorial › Academic › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...22 Next

ID: 62520